Debt-to-equity of GUIDED THERAPEUTICS INC from 30 Sep 2019 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
GUIDED THERAPEUTICS INC quarterly Debt-to-equity in % history and change rate from 30 Sep 2019 to 30 Sep 2025.
  • GUIDED THERAPEUTICS INC Debt-to-equity for the quarter ending 30 Sep 2025 was -120%, a 9.5% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

GUIDED THERAPEUTICS INC Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -120% +13% +9.5% 30 Sep 2025
Q2 2025 -122% +17% +12% 30 Jun 2025
Q1 2025 -125% +25% +17% 31 Mar 2025
Q4 2024 -129% +35% +22% 31 Dec 2024
Q3 2024 -133% +50% +27% 30 Sep 2024
Q2 2024 -139% +68% +33% 30 Jun 2024
Q1 2024 -150% +32% +18% 31 Mar 2024
Q4 2023 -164% +2.6% +1.6% 31 Dec 2023
Q3 2023 -183% -32% -21% 30 Sep 2023
Q2 2023 -207% -87% -72% 30 Jun 2023
Q1 2023 -182% -72% -65% 31 Mar 2023
Q4 2022 -167% -57% -52% 31 Dec 2022
Q3 2022 -151% -45% -42% 30 Sep 2022
Q2 2022 -120% -9.4% -8.5% 30 Jun 2022
Q1 2022 -110% +1.7% +1.5% 31 Mar 2022
Q4 2021 -110% -2.1% -2% 31 Dec 2021
Q3 2021 -106% +0.31% +0.29% 30 Sep 2021
Q2 2021 -111% -6.2% -5.9% 30 Jun 2021
Q1 2021 -112% -8.7% -8.4% 31 Mar 2021
Q4 2020 -108% -4.4% -4.3% 31 Dec 2020
Q3 2020 -106% -4.7% -4.6% 30 Sep 2020
Q2 2020 -104% 30 Jun 2020
Q1 2020 -103% 31 Mar 2020
Q4 2019 -103% 31 Dec 2019
Q3 2019 -102% 30 Sep 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.